Two Sigma Advisers’s Pfizer PFE Stock Holding History

Two Sigma Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,800	Closed	-$369K	–	1559
2025 Q4	$369K	Sell	14,800 -111,000	-88%	-$2.8M	﹤0.01%	1903
2025 Q3	$3.21M	Sell	125,800 -162,700	-56%	-$4.02M	0.01%	919
2025 Q2	$6.99M	Buy	288,500 +77,700	+37%	+$1.81M	0.01%	629
2025 Q1	$5.34M	Sell	210,800 -9,119,700	-98%	-$239M	0.01%	763
2024 Q4	$248M	Sell	9,330,500 -7,622,100	-45%	-$207M	0.57%	39
2024 Q3	$491M	Sell	16,952,600 -809,100	-5%	-$23.6M	1.15%	11
2024 Q2	$497M	Buy	17,761,700 +4,214,400	+31%	+$116M	1.11%	11
2024 Q1	$376M	Buy	13,547,300 +10,524,500	+348%	+$292M	0.87%	18
2023 Q4	$87M	Sell	3,022,800 -9,934,301	-77%	-$300M	0.2%	111
2023 Q3	$430M	Buy	12,957,101 +8,109,000	+167%	+$287M	1.1%	11
2023 Q2	$178M	Buy	4,848,101 +3,172,200	+189%	+$123M	0.45%	53
2023 Q1	$68.4M	Buy	1,675,901 +160,600	+11%	+$6.94M	0.18%	119
2022 Q4	$77.6M	Sell	1,515,301 -1,450,200	-49%	-$69.5M	0.22%	101
2022 Q3	$130M	Buy	2,965,501 +1,107,500	+60%	+$53.8M	0.38%	60
2022 Q2	$97.4M	Sell	1,858,001 -2,324,100	-56%	-$118M	0.28%	91
2022 Q1	$217M	Sell	4,182,101 -2,301,600	-35%	-$119M	0.58%	34
2021 Q4	$383M	Buy	6,483,701 +5,476,701	+544%	+$271M	0.96%	15
2021 Q3	$43.3M	Sell	1,007,000 -9,778,301	-91%	-$433M	0.11%	182
2021 Q2	$422M	Buy	10,785,301 +97,000	+0.9%	+$3.77M	1.11%	7
2021 Q1	$387M	Buy	10,688,301 +3,383,600	+46%	+$120M	1.06%	8
2020 Q4	$269M	Sell	7,304,701 -3,280,306	-31%	-$120M	0.72%	24
2020 Q3	$369M	Sell	10,585,007 -1,079,085	-9%	-$37.8M	1.05%	11
2020 Q2	$362M	Buy	11,664,092 +4,992,271	+75%	+$170M	1.06%	13
2020 Q1	$207M	Sell	6,671,821 -5,400,380	-45%	-$184M	0.79%	12
2019 Q4	$449M	Buy	12,072,201 +4,875,593	+68%	+$174M	1.04%	10
2019 Q3	$245M	Buy	7,196,608 +2,760,743	+62%	+$100M	0.6%	35
2019 Q2	$182M	Buy	4,435,865 +1,739,733	+65%	+$69.1M	0.45%	41
2019 Q1	$109M	Buy	2,696,132 +14,440	+0.5%	+$578K	0.27%	84
2018 Q4	$111M	Sell	2,681,692 -327,637	-11%	-$13.6M	0.3%	86
2018 Q3	$126M	Sell	3,009,329 -1,165,513	-28%	-$44.9M	0.31%	83
2018 Q2	$144M	Sell	4,174,842 -7,653,411	-65%	-$262M	0.39%	55
2018 Q1	$398M	Buy	11,828,253 +641,992	+6%	+$22.1M	1.08%	1
2017 Q4	$384M	Buy	11,186,261 +780,487	+8%	+$26.6M	1.04%	2
2017 Q3	$352M	Buy	10,405,774 +7,176,330	+222%	+$231M	1%	4
2017 Q2	$103M	Sell	3,229,444 -831,777	-20%	-$26.2M	0.34%	64
2017 Q1	$132M	Buy	4,061,221 +1,554,469	+62%	+$49M	0.43%	40
2016 Q4	$77.2M	Buy	2,506,752 +1,672,689	+201%	+$51.1M	0.3%	87
2016 Q3	$26.8M	Buy	834,063 +10,966	+1%	+$367K	0.11%	204
2016 Q2	$27.5M	Sell	823,097 -5,989,671	-88%	-$191M	0.14%	174
2016 Q1	$192M	Buy	6,812,768 +1,809,296	+36%	+$51.7M	1.07%	5
2015 Q4	$153M	Buy	5,003,472 +4,292,155	+603%	+$135M	0.91%	8
2015 Q3	$21.2M	Buy	+711,317	New	+$22.8M	0.13%	199
2015 Q1	–	Sell	-410,087	Closed	-$12.1M	–	2274
2014 Q4	$12.1M	Sell	410,087 -303,658	-43%	-$8.71M	0.09%	267
2014 Q3	$20M	Sell	713,745 -41,633	-6%	-$1.17M	0.15%	168
2014 Q2	$21.3M	Sell	755,378 -2,179,566	-74%	-$62.1M	0.17%	151
2014 Q1	$89.4M	Sell	2,934,944 -566,104	-16%	-$16.9M	0.81%	10
2013 Q4	$102M	Buy	3,501,048 +774,690	+28%	+$22.5M	0.98%	4
2013 Q3	$74.3M	Buy	2,726,358 +2,713,840	+21,680%	+$73.8M	0.89%	12
2013 Q2	$332K	Buy	+12,518	New	+$346K	﹤0.01%	1650

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Two Sigma Advisers's PFE Position: Q1 2026 in Review

Two Sigma Advisers sold out of Pfizer (PFE) in Q1 2026, closing a stake of 14,800 shares — an estimated $369K sold.

Two Sigma Advisers first reported a position in PFE in Q2 2013 and held it in 49 quarters. The position peaked at $497M in Q2 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Two Sigma Advisers reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 14,800 Pfizer shares in Q1 2026, an estimated $369K.
Two Sigma Advisers first reported a position in Pfizer in Q2 2013 and held it in 49 quarters.
Two Sigma Advisers's Pfizer position peaked at $497M in Q2 2024.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.